In the December 22, 2014, Federal Register, FDA announced the release of its final implementation plan for reviewing medical device submissions, published as part of an independent assessment of that process. The assessment is part of the FDA performance commitments relating to the Medical Device User Fee Amendments of 2012 (MDUFA III), which reauthorized device user fees for fiscal years 2013–2017.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
